These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9066834)

  • 21. Outcome of Stevens Johnson syndrome and toxic epidermal necrolysis treated with corticosteroids.
    Rijal A; Agrawal S
    Indian J Dermatol Venereol Leprol; 2009; 75(6):613-4. PubMed ID: 19915248
    [No Abstract]   [Full Text] [Related]  

  • 22. [Erythema multiforme in children versus Stevens-Johnson syndrome].
    Czubkowska I; Barszczak H; Koźniewska D; Wasaznik G
    Wiad Lek; 2000; 53(1-2):43-8. PubMed ID: 10806920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stevens-Johnson syndrome.
    Araujo OE; Flowers FP
    J Emerg Med; 1984; 2(2):129-35. PubMed ID: 6396327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Question 2: Would systemic steroids be useful in the management of Stevens-Johnson syndrome?
    Corrick F; Anand G
    Arch Dis Child; 2013 Oct; 98(10):828-30. PubMed ID: 24030508
    [No Abstract]   [Full Text] [Related]  

  • 26. Erythema multiforme and Stevens-Johnson syndrome. Descriptive and therapeutic controversy.
    Patterson R; Dykewicz MS; Gonzalzles A; Grammer LC; Green D; Greenberger PA; McGrath KG; Walker CL
    Chest; 1990 Aug; 98(2):331-6. PubMed ID: 2198136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced Lyell and Stevens-Johnson syndromes.
    Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
    Schneider JA; Cohen PR
    Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulin therapy for Stevens-Johnson syndrome.
    Brett AS; Philips D; Lynn AW
    South Med J; 2001 Mar; 94(3):342-3. PubMed ID: 11284525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stevens-Johnson syndrome: getting ready for the year 2000 and beyond.
    Patterson R; Tripathi A
    Ann Allergy Asthma Immunol; 1999 Nov; 83(5):339-40. PubMed ID: 10582711
    [No Abstract]   [Full Text] [Related]  

  • 31. Stevens-Johnson syndrome.
    Ban B; Bose S
    J Indian Med Assoc; 1965 Dec; 45(11):603-5. PubMed ID: 5842651
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.
    Ghislain PD; Roujeau JC
    Dermatol Online J; 2002 Jun; 8(1):5. PubMed ID: 12165215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
    Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
    Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Aihara M; Kano Y; Fujita H; Kambara T; Matsukura S; Katayama I; Azukizawa H; Miyachi Y; Endo Y; Asada H; Miyagawa F; Morita E; Kaneko S; Abe R; Ochiai T; Sueki H; Watanabe H; Nagao K; Aoyama Y; Sayama K; Hashimoto K; Shiohara T;
    J Dermatol; 2015 Aug; 42(8):768-77. PubMed ID: 25982480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stevens-Johnson syndrome in childhood.
    Blanco N; Gutiérrez B; Valls I; Puertas D; Martín C; Rivera M; Hernández Á; Torrelo A
    Arch Soc Esp Oftalmol; 2017 May; 92(5):241-244. PubMed ID: 27899204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stevens-Johnson syndrome in an HIV-infected patient.
    Blitz M; Spivack E; Kerpel SM; Freedman PD
    AIDS Read; 1999; 9(3):184-5, 190. PubMed ID: 12728904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Stevens-Johnson syndrome in the light of the literature and the author's personal observations].
    Struźak-Wysokińska M; Wysokiński A; Zwierzyńska W
    Czas Stomatol; 1979 Aug; 32(8):745-51. PubMed ID: 290455
    [No Abstract]   [Full Text] [Related]  

  • 38. Bilateral corneal perforations in Stevens-Johnson syndrome.
    Tabbara KF; Shammas HF
    Can J Ophthalmol; 1975 Oct; 10(4):514-7. PubMed ID: 1192271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A patient with Stevens-Johnson syndrome.
    Bond CA
    Nurs Times; 1980 Nov; 76(46):2013-5. PubMed ID: 6905022
    [No Abstract]   [Full Text] [Related]  

  • 40. [Systemic lupus erythematosus presenting as Stevens-Johnson syndrome].
    Bellakhal S; Ben Kaab B; Teyeb Z; Souissi A; Derbel F; Douggui MH
    Pathol Biol (Paris); 2015 Sep; 63(4-5):222-3. PubMed ID: 26088436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.